Dynavax Technologies | 매출원가



Cost Of Sales 변화 날짜
AbbVie USD 4.35B 344M 2025-06
Adma Biologics USD 54.22M 5.96M 2024-12
Amgen USD 2.6B 507M 2025-03
AstraZeneca USD 2.47B 232M 2025-06
Biogen USD 605M 24.3M 2025-06
BioMarin Pharmaceutical USD 154.94M 3.38M 2025-06
Bristol-Myers Squibb USD 3.37B 339M 2025-06
Dynavax Technologies USD 14.04M 13.5M 2025-06
Gilead Sciences USD 1.5B 39M 2025-06
Glaxosmithkline GBP 2.52B 199M 2024-12
Merck USD 2.82B 53M 2025-06
Neurocrine Biosciences USD 11.3M 2.1M 2025-06
Novartis USD 3.32B 95M 2025-06
Pfizer USD 4.99B 2.4B 2025-06
Regeneron Pharmaceuticals USD 530.2M 264.7M 2025-06
Roche Holding CHF 4.13B 393.5M 2024-12
Sarepta Therapeutics USD 153.22M 15.66M 2025-06
TG Therapeutics USD 18.94M 3.4M 2025-06
Vertex Pharmaceuticals USD 407.5M 44.5M 2025-06


Dynavax Technologies 매출원가 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Aug 2025.